• 12/11/2022
    • 0
    FECAVA supports BSAVA and RCVS Knowledge Campaign: Veterinary Antibiotic Amnesty

    FECAVA supports BSAVA and RCVS Knowledge Campaign: Veterinary Antibiotic Amnesty

    For the first time, the veterinary profession in UK is working with NHS England (Midlands) to launch a pioneering campaign that encourages the public to return out-of-date and unused antibiotics to help tackle the growing issue of antimicrobial resistance (AMR) launched by BSAVA and RCVS Knowledge. The antibiotic amnesty is taking place during November 2022,

    Read more
    • 12/11/2022
    • 0
    2022 WSAVA guidelines  for the recognition, assessment and treatment of pain

    2022 WSAVA guidelines for the recognition, assessment and treatment of pain

    The WSAVAโ€™s Global Pain Council launched an updated set of Global Guidelines for the Recognition, Assessment and Treatment of Pain, during World Congress. They have been published by the Journal of Small Animal Practice (JSAP). A key feature is an emphasis on the use of pain scales for the assessment of acute and chronic pain

    Read more
    • 12/11/2022
    • 0
    AAFP/ISFM Cat-Friendly Guidelines

    AAFP/ISFM Cat-Friendly Guidelines

    Veterinary professionals worldwide will now have access to two new Cat Friendly Guidelines that promote positive, respectful interactions with their feline patients and reduce the stress associated with the veterinary environment. Published jointly by the International Society of Feline Medicine (ISFM) and the American Association of Feline Practitioners (AAFP), the โ€˜2022 AAFP/ISFM Cat Friendly Veterinary

    Read more
    • 22/09/2022
    • 1
    2022 Feline Infectious peritonitis (FIP) Diagnosis Guidelines

    2022 Feline Infectious peritonitis (FIP) Diagnosis Guidelines

    Feline infectious peritonitis (FIP) has gained a lot of attention recently. Research has demonstrated new antivirals effective for treatment of this once fatal disease. Unfortunately, these products are not legally available in many countries at this time, so we should keep attention to clinical trials and new drug approvals. Not only treatment but also diagnosis

    Read more
X